Thomas Tu - 27 Feb 2023 Form 4 Insider Report for Inari Medical, Inc.

Role: Chief Medical Officer
Signature: /s/ Angela Ahmad, attorney-in-fact for Thomas Tu
Issuer symbol: N/A
Transactions as of: 27 Feb 2023
Net transactions value: -$562,649
Form type: 4
Filing time: 01 Mar 2023, 17:13:43 UTC
Previous filing: 22 Feb 2023
Next filing: 14 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NARI	Common Stock	Options Exercise	$4,570	+10,000	+9.3%	$0.4570^*	117,112	27 Feb 2023	Direct	F1
transaction	NARI	Common Stock	Sale	$358,669	-6,347	-5.4%	$56.51	110,765	27 Feb 2023	Direct	F1, F2
transaction	NARI	Common Stock	Sale	$208,550	-3,653	-3.3%	$57.09	107,112	27 Feb 2023	Direct	F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NARI	Stock Option	Options Exercise	$0	-10,000	-6.7%	$0.000000	139,584	27 Feb 2023	Common Stock	10,000	$0.4570	Direct	F1, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022.
F2	This transaction was executed in multiple trades at prices ranging from $56.02 to $57.00 The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3	This transaction was executed in multiple trades at prices ranging from $57.04 to $57.13 The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4	The option vested with respect to 25% of the underlying shares on April 23, 2020, and vests with respect to the remaining shares in 36 equal monthly installments thereafter.